News for CODX Stock

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025 Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025 Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024 Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024 Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3 Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21 Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024 Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12 Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023 Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for November 2023 Co-Diagnostics, Inc. Announces Third Quarter 2023 Earnings Release Date and Webcast Co-Diagnostics, Inc. to Host Booth at CASMET Symposium October 23-25 Co-Diagnostics, Inc. to Host Booth at Medlab Africa 2023 in Johannesburg, South Africa Co-Diagnostics, Inc. to Participate in the 2023 UHCA/UCAL Fall Convention & Expo on Sept 27-28 Co-Diagnostics, Inc. to Participate in 6th ACTC Conference in Skiathos, Greece Co-Diagnostics, Inc. to Participate in Gilmartin Group Annual Emerging Growth Showcase on Sept 21 Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 25th Annual Global Investment Conference on September 11-13, 2023 Co-Diagnostics, Inc. to Present at 15th Next Generation Dx Summit in Washington, D.C. Co-Diagnostics, Inc. to Host Booth at Medlab Asia Conference in Bangkok, Thailand Co-Diagnostics, Inc. Reports Second Quarter 2023 Financial Results Co-Diagnostics, Inc. Announces Second Quarter 2023 Earnings Release Date and Webcast Co-Diagnostics, Inc. to Host Booth and Discuss Recent Grant Awards at AACC 2023 in Anaheim, CA Co-Diagnostics, Inc. Announces Recent Grant Awards Co-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home Platform from NIH RADx® Tech Program Co-Diagnostics, Inc. Reports First Quarter 2023 Financial Results Co-Diagnostics, Inc. to Host Booth at Senior Living Executive Conference in New Orleans, LA Co-Diagnostics, Inc. Announces First Quarter 2023 Earnings Release Date and Webcast Co-Diagnostics, Inc. to Host Booth at 67th Annual CARPHA Conference April 27-29 Co-Diagnostics, Inc. to Host Booth at ECCMID 2023 April 15-18 in Copenhagen, Denmark Co-Diagnostics, Inc. to CEO to Deliver Keynote Address at 2023 MarketsandMarkets Conference in London, England Co-Diagnostics, Inc. to Host Booth at 10th Gene Quantification Event in Munich, Germany, March 20-22 Co-Diagnostics, Inc. Reports Full Year 2022 Financial Results CO-DIAGNOSTICS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 EARNINGS RELEASE DATE AND WEBCAST Co-Diagnostics, Inc. to Present and Host Booth at TRI-CON in San Diego, CA, March 6-8 Co-Diagnostics, Inc. to Host Booth at 89th Annual AMCA Conference in Reno, NV on Feb 28-March 3 Co-Diagnostics, Inc. Initiates Clinical Evaluations for its At-Home and Point-of-Care Co-Dx PCR Home™ Platform Co-Diagnostics, Inc. to Host Booth at Medlab Middle East 2023 in Dubai on February 6-9 Co-Diagnostics, Inc. Commemorates Third Anniversary of the Completion of its First COVID-19 Test Design Co-Diagnostics, Inc. to Host Booth at CES 2023 January 5-8 Co-Diagnostics, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference on December 1, 2022 Co-Diagnostics, Inc. to Host Booth at MEDICA 2022 Trade Fair in Düsseldorf, Germany Co-Diagnostics, Inc. Reports Third Quarter 2022 Financial Results Co-Diagnostics, Inc. to Host Booth at AMP This Week in Phoenix, AZ Co-Diagnostics, Inc. Appoints Dr. Mark Poritz as New Chief Scientific Officer CO-DIAGNOSTICS, INC. ANNOUNCES THIRD QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST Co-Diagnostics, Inc. to Host Booth at Medlab Africa on Oct 26-28 in South Africa Co-Diagnostics, Inc. to Host Booths at Conferences in Washington, D.C. and Bangkok, Thailand Co-Diagnostics, Inc. to Sponsor, Present, and Host Booth at 66th Annual CARPHA Conference on Sept 15-17 in Jamaica Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022 Co-Diagnostics, Inc. to Host Booth at Medical Fair Asia 2022 in Singapore on Aug 31-Sep 2 Co-Diagnostics, Inc. to Present at 14th Next Generation Dx Summit in Washington, D.C. Co-Diagnostics, Inc. Reports Second Quarter 2022 Financial Results Co-Diagnostics, Inc. to Participate in Yale University SalivaDirect™ Conference Held July 28-29 in Chicago Co-Diagnostics, Inc. to Announce Expansion of OEM Agreement with Bio Molecular Systems at AACC Co-Diagnostics, Inc. to Host Booth at AACC Held July 24-28 in Chicago Co-Diagnostics, Inc. Announces Shipment of Monkeypox Virus Test Co-Diagnostics, Inc. to Present at 29th International Biodetection Technologies Virtual Conference Co-Diagnostics, Inc. to Present at Sidoti Summer Small Cap Virtual Conference Co-Diagnostics, Inc. to Host Booth at MEDEXPO Africa 2022 in Nairobi, Kenya on June 9-11 Co-Diagnostics, Inc. Completes Principal Design of Test for Monkeypox Virus Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 Global Investment Conference on May 23-26 Co-Diagnostics Reports Solid First Quarter 2022 Financial Results Co-Diagnostics, Inc. to Host Booth at Medical Fair Brasil 2022 in São Paulo on May 3-6 CO-DIAGNOSTICS, INC. ANNOUNCES FIRST QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST Co-Diagnostics, Inc. to Host Booth at ECCMID 2022 in Lisbon, Portugal on April 23-26 Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis C Viral Load Test Co-Diagnostics Reports Full Year 2021 Financial Results Co-Diagnostics, Inc. to Present at MarketsandMarkets Conference on March 23-24 in London, England Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board Co-Diagnostics, Inc. Announces Authorization of $30 Million Share Repurchase Program CO-DIAGNOSTICS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 EARNINGS RELEASE DATE AND WEBCAST Co-Diagnostics, Inc. to Sponsor and Present at Molecular Med Tri-Con 2022 Co-Diagnostics, Inc. to Host Booth at Life Sciences Day on the Hill on February 16 at the Utah State Capital Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis B Viral Load Test Co-Diagnostics, Inc. to Host Booth at Medlab Middle East 2022 in Dubai on January 24-27 Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex Test Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 BioConnect Virtual Conference on January 10-13 Co-Diagnostics, Inc. Announces Completion of the Acquisition of all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform Co-Diagnostics, Inc. Signs Agreement to Acquire all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform Creator of COVID-19 and Global Molecular Testing Products Co-Diagnostics, Inc. Launches Retail Investor and Perks Program with TiiCKER Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for ABC Multiplex Test Co-Diagnostics, Inc. Reports that Suite of COVID-19 Diagnostics Not Affected by Heavily Mutated Omicron Variant Co-Diagnostics, Inc. to Host Booth at MEDICA 2021 Trade Fair in Düsseldorf, Germany Co-Diagnostics Reports Continued Strength in Third Quarter 2021 Financial Results Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Test Approved for Use in the United Kingdom Co-Diagnostics, Inc. Announces Third Quarter 2021 Earnings Release Date And Webcast Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for Dengue/Chikungunya Multiplex Test Co-Diagnostics, Inc. to Introduce At Home/Point of Care Device at AACC on Sept 28 Co-Diagnostics, Inc. Announces Corporate Rebranding Following Period of Transformative Growth and Expansion Co-Diagnostics, Inc. to Present at ACTC Liquid Biopsy Conference in Kalamata, Greece Co-Diagnostics, Inc. Logix Smart™ ABC Test Authorized for Use in Mexico Co-Diagnostics, Inc. to Present at Sidoti Virtual Investor Conference Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for Chikungunya and Dengue Tests Co-Diagnostics, Inc. CEO to Participate in Panel Discussion with Scott Gottlieb, M.D., at H.C. Wainwright 2021 Annual Global Investor Conference Co-Diagnostics, Inc. SARS-CoV-2 Test Used in New Community Surveillance Method in Italy Co-Diagnostics, Inc. To Present At 13th Next Generation Dx Summit In Washington, D.C. Co-Diagnostics Reports Strong Second Quarter 2021 Financial Results Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And Webcast Co-Diagnostics, Inc. Strengthens Intellectual Property Portfolio with New International CoPrimer™ Patent Co-Diagnostics, Inc Receives CE Marking for Direct Saliva SARS-CoV-2 Test Co-Diagnostics, Inc. to Present at Upcoming Technology and Health Research Conferences Co-Diagnostics, Inc. Announces First-Quarter 2021 Earnings Release Date and Webcast Co-Diagnostics, Inc. and Partner CRL to Discuss Saliva Testing and Future Applications of PCR in 360Dx Webinar Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India Co-Diagnostics, Inc. Test Performance Demonstrated by Australian Researchers in Peer-Reviewed Publication Co-Diagnostics, Inc. CEO Discusses Company Strategy for the Future with Yahoo! Finance Co-Diagnostics Reports Fourth-Quarter and Full-Year 2020 Financial Results Co-Diagnostics, Inc. Announces Fourth-Quarter and Full-Year 2020 Earnings Release Date and Webcast Co-Diagnostics Invited to Present at Maxim Group LLC Emerging Growth Virtual Conference Co-Diagnostics to Present Point-of-Care and At Home Testing Platform at Infectious Disease Diagnostics Virtual Conference Co-Diagnostics to Discuss Recent Company Advances at H.C. Wainwright Global Life Sciences Virtual Conference Co-Diagnostics New Rapid PCR Point-of-Care and at Home Testing Platform to Detect Covid-19 and Other Diseases Using CoPrimer™ Technology Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer™-Based COVID-19 PCR Test Through Walgreens Find Care® Clinical Reference Laboratory Makes First At-Home COVID-19 Saliva Test Available Through Walgreens Find Care® Co-Diagnostics, Inc. Announces New Chief Financial Officer Co-Diagnostics, Inc. to Present on Direct Saliva Testing Technology at Molecular Med Tri-Con Co-Diagnostics Completes FDA EUA Submission for Extraction-Free Saliva COVID-19 Test Co-Diagnostics to Present at H.C. Wainwright BioConnect 2021 Virtual Conference Co-Diagnostics Anticipates Reporting Highest Quarterly Revenue Following Demand for COVID-19 Diagnostic Products Co-Diagnostics Designs Test to Detect Mutations for New Coronavirus Strain Using CoPrimer™ Platform Co-Diagnostics Announces Milestone of Over 10 Million COVID-19 Tests Sold Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test Co-Diagnostics, Inc. Receives CE Markings for "ABC" and SARS-CoV-2 2-Gene Multiplex Tests Co-Diagnostics, Inc. Announces Q3 2020 Financial Results Including YTD Net Income per Common Share of $1.07 Co-Diagnostics, Inc. CoPrimers™ Shown to be Effective in COVID-19 Saliva PCR Tests Without Sample Extraction Co-Diagnostics, Inc. Announces Q3 2020 Earnings Release Date and Earnings Webcast Co-Diagnostics, Inc. to Amend Q2 2020 Form 10-Q to Show $0.51 Net Income per Share Co-Diagnostics, Inc. Logix Smart Kit to be Used with Newly Authorized Saline Oral Rinse Collection Co-Diagnostics, Inc. Provides Update on "ABC" Test for Influenza A, Influenza B, and COVID-19 Co-Diagnostics, Inc. Announces Details to Access Presentation at H.C. Wainwright Global Investment Conference Co-Diagnostics, Inc. Issues Operational Update Co-Diagnostics, Inc. To Discuss Recent Company Growth and Upcoming Expansion Plans at H.C. Wainwright Global Investment Conference Co-Diagnostics, Inc. Receives Enhanced U.S. Patent Protection for CoPrimer Technology Used in COVID-19 Test Co-Diagnostics, Inc. Announces Q2 2020 Results on Form 10-Q Co-Diagnostics, Inc. Announces Q2 2020 Earnings Release Date and Earnings Webcast Co-Diagnostics, Inc. Logix Smart™ COVID-19 Test Authorized for Use in Australia Co-Diagnostics, Inc. Technology to be Used in FDA-Authorized Self-Collected COVID-19 Saliva Test